[go: up one dir, main page]

MX2022006424A - Analogos de equinocandina y metodo de preparacion de los mismos. - Google Patents

Analogos de equinocandina y metodo de preparacion de los mismos.

Info

Publication number
MX2022006424A
MX2022006424A MX2022006424A MX2022006424A MX2022006424A MX 2022006424 A MX2022006424 A MX 2022006424A MX 2022006424 A MX2022006424 A MX 2022006424A MX 2022006424 A MX2022006424 A MX 2022006424A MX 2022006424 A MX2022006424 A MX 2022006424A
Authority
MX
Mexico
Prior art keywords
preparation
echinocandine
analogs
preventing
compound
Prior art date
Application number
MX2022006424A
Other languages
English (en)
Inventor
Wei Jiang
Jian Huang
Lingjian Zhu
Weicou Cao
Original Assignee
Shanghai Senhui Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Senhui Medicine Co Ltd filed Critical Shanghai Senhui Medicine Co Ltd
Publication of MX2022006424A publication Critical patent/MX2022006424A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a un análogo de equinocandina y a un método de preparación del mismo. El compuesto se puede usar para prevenir o tratar infecciones fúngicas, o para prevenir, estabilizar o inhibir el crecimiento fúngico o matar hongos. Un compuesto ejemplar está representado por la Formula I, en donde las definiciones de los grupos R1, R2, R3 y G son como se revelan en la descripción. (ver Fórmula).
MX2022006424A 2019-12-06 2020-12-04 Analogos de equinocandina y metodo de preparacion de los mismos. MX2022006424A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN201911241526 2019-12-06
CN201911249226 2019-12-09
CN202010165349 2020-03-11
CN202010799506 2020-08-11
CN202011164541 2020-10-27
CN202011371550 2020-11-30
PCT/CN2020/133815 WO2021110125A1 (zh) 2019-12-06 2020-12-04 棘白菌素类似物及其制备方法

Publications (1)

Publication Number Publication Date
MX2022006424A true MX2022006424A (es) 2022-06-22

Family

ID=76222453

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022006424A MX2022006424A (es) 2019-12-06 2020-12-04 Analogos de equinocandina y metodo de preparacion de los mismos.

Country Status (11)

Country Link
US (2) US12466856B2 (es)
EP (1) EP4063381A4 (es)
JP (2) JP7794736B2 (es)
KR (1) KR20220110513A (es)
CN (3) CN120484067A (es)
AU (1) AU2020397311A1 (es)
BR (1) BR112022010441A2 (es)
CA (1) CA3161287A1 (es)
MX (1) MX2022006424A (es)
TW (1) TWI891685B (es)
WO (1) WO2021110125A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240262866A1 (en) * 2021-06-03 2024-08-08 Shanghai Senhui Medicine Co., Ltd. Method for preparing anidulafungin derivative
AU2023370368A1 (en) * 2022-10-25 2025-06-05 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Pharmaceutical composition comprising echinocandin analog and preparation method for pharmaceutical composition
CN116903706B (zh) * 2023-06-13 2024-05-17 深圳市祥根生物有限公司 一种棘白菌素类药物及其制备方法和用途
WO2025152953A1 (zh) * 2024-01-15 2025-07-24 深圳市祥根生物有限公司 棘白菌素类化合物的抗肿瘤用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US5914313A (en) * 1991-10-17 1999-06-22 Merck & Co., Inc. 1- 4-hydroxy-5-aminoethyloxy-N2 -(10,12-dimethyl-1-oxotetradecyl)ornithine!-5-(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandin B, other aminoalkyl derivatives and salts thereof
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
JP2013503179A (ja) 2009-08-27 2013-01-31 シーチェイド ファーマシューティカルズ,インコーポレーテッド エキノキャンディン誘導体
PT2680873T (pt) 2011-03-03 2017-11-01 Cidara Therapeutics Inc Agentes antifúngicos e suas utilizações
WO2016201283A1 (en) * 2015-06-12 2016-12-15 Cidara Therapeutics, Inc. Antifungal agents
US20180256673A1 (en) 2015-09-16 2018-09-13 Cidara Therapeutics, Inc. Methods for treating fungal infections
EP3399995A4 (en) 2016-01-08 2019-08-21 Cidara Therapeutics, Inc. METHOD FOR PREVENTING AND TREATING PNEUMOCYSTIS INFECTIONS
WO2018102407A1 (en) 2016-11-29 2018-06-07 Cidara Therapeutics, Inc Methods for preventing fungal infections

Also Published As

Publication number Publication date
JP7794736B2 (ja) 2026-01-06
KR20220110513A (ko) 2022-08-08
TWI891685B (zh) 2025-08-01
CN114616238B (zh) 2025-04-11
CN120484067A (zh) 2025-08-15
CN114616238A (zh) 2022-06-10
JP2023504389A (ja) 2023-02-03
AU2020397311A1 (en) 2022-07-14
US20230159591A1 (en) 2023-05-25
CA3161287A1 (en) 2021-06-10
CN120484066A (zh) 2025-08-15
JP2026001045A (ja) 2026-01-06
TW202134257A (zh) 2021-09-16
BR112022010441A2 (pt) 2022-09-06
US20250353879A1 (en) 2025-11-20
WO2021110125A1 (zh) 2021-06-10
EP4063381A4 (en) 2023-04-26
US12466856B2 (en) 2025-11-11
EP4063381A1 (en) 2022-09-28

Similar Documents

Publication Publication Date Title
MX2022006424A (es) Analogos de equinocandina y metodo de preparacion de los mismos.
ECSP20044709A (es) Inhibidores de sarcómero cardíaco
ECSP21016009A (es) Inhibidores de sarcómeros cardíacos
EA201991312A1 (ru) Комбинации активных соединений
EA201991349A1 (ru) Тетрациклические гетероциклические соединения, полезные в качестве ингибиторов интегразы вич
BR112023000205A2 (pt) Misturas fungicidas
UA117518C2 (uk) 6-конденсовані гетероарилдигідропіримідини для лікування та профілактики зараження вірусом гепатиту b
MX2019002978A (es) Composiciones que comprenden una bacteria no patogena y metodos para proteger plantas y animales anfitriones contra enfermedades micoticas, bacterianas y virales.
PH12019500432B1 (en) 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection
PH12017502009A1 (en) Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
EA201892815A1 (ru) Новые антибактериальные соединения
JOP20200326A1 (ar) مشتقات تترا هيدرو ثينوبيريدين بها استبدال بـ n واستخداماتها
EA201692189A1 (ru) Соединения фосфина золота (i) в качестве антибактериальных агентов
UY37764A (es) Nuevos compuestos inhibidores de la prostaglandina d sintasa hematopoyética (h-pgds)
MX385971B (es) Compuesto de griseofulvina.
EA201692190A1 (ru) Соединения фосфина золота (i) в качестве антибактериальных агентов
UY38591A (es) Compuestos de diona cíclica herbicidamente activos que comprenden un grupo oxima o hidrazona.
SA522441650B1 (ar) مثبطات فوسفوينوسيتيد 3-كيناز الموضعية
ZA202107046B (en) Fungicidal aryl amidines
EA201690802A1 (ru) Сельскохозяйственное или садоводческое химическое средство, способ борьбы с болезнями растений и продукт для борьбы с болезнями растений
PH12020551117A1 (en) Compositions for preventing or treating uveitis
EA201992509A1 (ru) Гетероарилфениламинохинолины и аналоги
EA201690737A1 (ru) Сельскохозяйственное или садоводческое химическое средство, способ борьбы с болезнями растений и продукт для борьбы с болезнями растений
EA201690801A1 (ru) Сельскохозяйственное или садоводческое химическое средство, способ борьбы с болезнями растений и продукт для борьбы с болезнями растений
UY38264A (es) N- (tetrazol-5-il)- y carboxamidas de n- (1,3,4-oxadiazol-2-il) arilo